VolitionRx
Business Services · Nevada, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1489 W Warm Springs Rd Ste 110, Henderso...Phone Number
(702) 425-1561Website
www.volition.comRevenue
<$5 MillionStock Symbol
VNRXIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
1
1
1
1
1
About VolitionRx
Volition is a multinational epigenetic company focused on advancing the science of epigenetics. It is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, the company is developing and commercializing simple, easy-to-use, cost-effective blood tests designed to help diagnose and monitor a range of diseases, including certain cancers and conditions associated with NETosis, such as sepsis.Explore more
VolitionRx Org Chart
JK
Chief Executive Officer, Singapore Volition
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is VolitionRx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once VolitionRx has new funding data
Check out if VolitionRx is spiking on competitors!
Earning: See what the market has to say on VolitionRx recently announced quarterly report
Check if VolitionRx has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
VolitionRx, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when VolitionRx launches new products
Click to see if VolitionRx had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at VolitionRx
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at VolitionRx
Find 3 more new buyers
Compare Similar Companies to VolitionRx
Compare insights from companies similar to VolitionRx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
VolitionRx
<$5M
51-200
Public
$11.3M
2010
Tom ButeraCEO (Volition Veterinary Diagnostics Development LLC)
Company Profile Activity
Activity Insights
VolitionRx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
VolitionRx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about VolitionRx.
VolitionRx financials insights
Gather financial insights about VolitionRx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Private Equity
$1.5M
2023
Debt
$5.5M
2026
Stock/Share Issuance
$2M
Other Financing Round
$2.3M
VolitionRx Tech Stack
A closer look at the technologies used by VolitionRx
Most Recent Scoops
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Funding
Funding
Funding
Funding
VolitionRx News & Media
Volition Advances Nu.Q® NETs Platform Towards Commercialization
Consistent international data positions Nu.Q® H3.1 as a potential "game changer" in sepsis management within a $3.8 billion addressable market HENDERSON, Nev., July 30, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today...VolitionRx Announces Data Showing the Prognostic Value of its Nu.Q® Cancer Test
HENDERSON, Nev., July 7, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the release of a new clinical study demonstrating the significant prognostic value of its Nu.Q® Cancer Assay in newly diagnosed lung...VolitionRx Converts Debt to Equity Through Share Issuances - The Globe and Mail
Detailed price information for Volitionrx Ltd (VNRX-A) from The Globe and Mail including charting and trades.VolitionRx Announces Collaboration with Sysmex
HENDERSON, Nev., June 17, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces a collaboration with Sysmex (TYO: 6869), a leader in global in vitro diagnostics, to optimize Volition's Nu.Q® NETs H3.1 assay on the...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VolitionRx
Sign Up For FreeTo access detailed company insights
Volition is a multinational epigenetic company focused on advancing the science of epigenetics. It is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, the company is developing and commercializing simp... Read More
